跳至主要内容
临床试验/NCT04907058
NCT04907058已完成不适用

Central Sleep Apnea Treated by CO2 Supplied by a Novel Device

State Key Laboratory of Respiratory Disease1 个研究点 分布在 1 个国家目标入组 18 人开始时间: 2021年5月20日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
18
试验地点
1
主要终点
Oxygen Desaturation Index

研究概览

简要总结

In general, central sleep apnea is not as common as obstructive sleep apnea but it is common in patients with heart failure. It has been repeatedly shown that central sleep apnea worsens the prognosis of heart failure. The current concept in the development of CSA is hypocapnia which causes temporary cessation of respiratory neural output. Different methods for supplement of CO2 have been used to eliminate CSA. However, variation of CO2 concentration during overnight treatment and tight-fitting mask made the treatment uncomfortable. It is important to develop a device with a comfortable mask to supply constant low dose CO2 without breathing difficulty. We recently developed a device for treatment of CSA.

详细描述

Objective

To determine whether the device could improve sleep quality while eliminating CSA during the overnight study. Methods: Patients with central sleep apnea diagnosed by diaphragm EMG will be recruited in this study. CO2 concentration for treatment would be manually titrated during overnight PSG. Patients were then treated with an effective lowest concentration of CO2 derived from titration under PSG on the third night. The sleep apnea hypopnea index (AHI), central sleep apnea index (CHI), arousal index (ArI), Oxygen desaturation index (ODI), sleep structure, blood pressure, heart rate, diaphragm EMG, treatment side effects and treatment preference were to be observed.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Sequential
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 82 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Willing to participate after informed consent
  • Males and females, any race and aged≥18yeras
  • Objectively confirmed central sleep apnea/Cheyne Stokes Respiration with an apnoea-hypopnoea- index (AHI)≥5/h by overnight polysomnography

排除标准

  • Obstructive sleep apnea
  • Severe COPD,FEV1/FVC<70% and FEV1<60%
  • Chronic CO2 retention with unknown reason
  • Severe nasal congestion
  • Poor understanding

结局指标

主要结局

Oxygen Desaturation Index

时间窗: One full night

Total number of oxygen desaturations≥3% /total sleep time(h)

Apnea Hypopnea Index

时间窗: One full night

Total number of apneas and hypopneas/total sleep time (h)

Central sleep apnea index

时间窗: One full night

Total number of central sleep apneas/total sleep time (h)

Arousal Index

时间窗: One full night

Total number of arousals/total sleep time(h)

Adverse effects

时间窗: One full night

Using questionnaire named side effects of feeling to assess adverse effects exiting or not, including dyspnea, noise, bloating, itchy face, dry mouth, ophthalmalgia, stuffy nose, et al. When the side effect events in intervening condition 2 times more than baseline is worse outcome.

Sleep structure

时间窗: One full night

Assessment of the sleep efficiency (percentage is calculated by dividing Total Sleep Time by Total Time in bed)

次要结局

未报告次要终点

研究者

发起方
State Key Laboratory of Respiratory Disease
申办方类型
Other
责任方
Principal Investigator
主要研究者

Yuan-Ming Luo

Proffessor

State Key Laboratory of Respiratory Disease

研究点 (1)

Loading locations...

相似试验